Cell & Gene Sourcing Center
The number of clinical trials in cell and gene therapy has exploded – estimates are of over 1,000 clinical trials ongoing globally.
Many of these new therapeutic approaches require the production of viral vectors. Viral vector manufacturing today is cumbersome, and the yields are poor. If you are a startup biotech in need of viral vectors today, getting into capacity could be an issue. Complicating matters, cell and gene therapies require a certain proximity to patient and process/treatment centers, which will keep most U.S.-based drug and therapy developers looking for domestic (and regional) partners.
How can we help?
Looking for help with your Cell & Gene project? If you're searching for information or a supplier, let Life Science Connect lend you a hand.
Cell & Gene CMOs
3PBIOVIAN
3PBIOVIAN is a globally operating CDMO supporting your biologics and advanced therapies. We are proud to partner with our customers at every stage of their journey, from early-stage development to commercial manufacturing. Our services include microbial and mammalian protein expression platforms, viral vector production for AAV, cell therapy, and plasmid DNA production.
Capabilities
AGC Biologics
AGC Biologics is a leading global biopharmaceutical CDMO committed to delivering the highest standard of service and collaboration to our clients and partners as we work side-by-side to help bring their products to patients across the globe. We offer world-class development and manufacturing services of mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), messenger RNA (mRNA) viral vectors, and genetically engineered cells.
Ajinomoto Bio-Pharma Services
Working with Ajinomoto Bio-Pharma Services, you get a trusted CDMO partner that has the power to make your every challenge our own, sharing your unwavering tenacity and dedication from pre-clinical program to commercial successes. We leverage our broad range of capabilities and services at our sites in Belgium, India, Japan, and the US to support your program goals.
Capabilities
Have questions about selecting the right CMO?
The Life Science Connect team can help. We'll match your needs with the right companies.
Contact us via email for assistance.
Aldevron
For 25 years Aldevron has been a catalyst, advancing therapeutic and vaccine development through expert plasmid DNA, RNA, and protein custom manufacturing, supporting our clients from discovery to commercialization. Our custom CDMO services have given scientists around the world essential components to accelerate their research and make a difference. Whether you're working on a gene therapy, cell therapy, or vaccine development, it starts with a high-quality DNA, RNA, or Protein.
Andelyn Biosciences
Andelyn Biosciences is a pioneering gene therapy organization born out of Nationwide Children's Hospital, where the first FDA-approved systemic gene therapy was discovered.
With more than 15 years of experience in AAV vector manufacturing, Andelyn is a full-spectrum CDMO. We bring scalability, capacity, efficiency and expert resources to manufacturing matrices, all to advance the development of viral vector-based therapeutics.
Capabilities
Applied StemCell
Founded in 2008, Applied StemCell empowers researchers with iPSC and gene editing technologies for advanced therapeutic discovery. Our products and services support basic research to early-stage GMP manufacturing, including disease modeling, iPSC services, drug screening, and pre-IND studies. With patented technologies, we provide a clear IP path to commercialization, driving innovation in regenerative medicine and gene therapy.
Capabilities
Ascend & ABL Inc.
Ascend Advanced Therapies (Ascend) is a gene-to-GMP contract, development, and manufacturing organization (CDMO) built on decades of biomedical research and therapeutic development expertise. Capabilities span early-stage discovery work, optimization, process development, regulatory support, and drug-substance to GMP manufacturing.
Capabilities
Catalent
Catalent is a global leader in providing integrated services, superior drug delivery technologies and manufacturing solutions to help life science innovators develop and launch successful pharmaceuticals, biologics and consumer health products.
Capabilities
Cencora
Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. We are united in our responsibility to create healthier futures.
Comprehensive Cell Solutions, A Business Unit of NYBC Enterprises
Founded in 2003 as a business unit of New York Blood Center Enterprises, Comprehensive Cell Solutions offers its deep expertise in the development and manufacture of cell and gene therapies, using its GMP and GTP facilities. CCS provides a true vein-to-vein solution, spanning fresh cellular collections and cord blood-derived stem cells as source material, to cell isolation, manipulation and cryopreservation for preclinical to commercial products.
Cytiva
With a rich heritage dating back hundreds of years, Cytiva brings a wealth of technical expertise and talent, a broad and deep portfolio, and exceptional service help researchers and biopharma advance therapeutics at every stage from discovery to delivery. We supply the tools and support our customers need to work better, faster, and safer, leading to the delivery of transformative medicines to patients.
ElevateBio
ElevateBio is a technology-driven company accelerating transformative cell and gene therapies through its integrated ecosystem. Combining platforms like Life Edit gene editing, iPSC, and RNA/cell/vector engineering with BaseCamp®, its cGMP manufacturing arm, ElevateBio enables biotech partners and advances its own pipeline of regenerative medicines — positioning itself as a leading force in reshaping disease treatment through cellular and genetic innovation.
Capabilities
Excellos
Excellos is a focused CDMO combining boutique-level support with robust scientific and operational expertise. From donor material to final product, we deliver tailored solutions across the development lifecycle. Our agile, collaborative model ensures speed, quality, and scalability. Backed by clinical experience, a partnership with the San Diego Blood Bank, and a culture of rigor, we help partners advance confidently and efficiently.
Capabilities
FUJIFILM Diosynth Biotechnologies
FUJIFILM Diosynth Biotechnologies is a CDMO Partner for Life. We combine technical leadership in cell culture, microbial fermentation and advanced therapies with world class cGMP manufacturing facilities and superior program management to advance tomorrow's medicines.
GC Cell
GC Cell stands at the forefront of cell therapy innovation, offering a holistic approach that encompasses everything from research and development to bringing products to market. Our mission is to fast-track the innovation in cell and gene therapies, aiming to enhance the clinical outcomes of each & every patient and shape the future of healthcare.
Capabilities
HERMA
HERMA as a world leading manufacturer of self-adhesive label application systems designs and builds high specification, high quality labeling equipment and has a range of standard and special purpose machinery. Our labeling machines, with the HERMA 500 high-performance labeler at their core, guarantee quality, flexibility, connectivity and support around the globe. We create added value throughout the process with our superior strength in consulting, implementation and service.
Capabilities
IDT Biologika
IDT Biologika is a global CDMO for Innovative Vaccines, Cell & Gene Therapeutics and Aseptic Fill-Finish of other biologics. We offer clients a single source CDMO partner at our sites in Germany and the USA, with seamless end-to-end solutions and the ability to nimbly scale projects from development through to commercialization. This includes Process Development, Drug Substance Manufacturing, Sterile Dosage Fill-Finish, Labelling & Packaging, Quality Control & Analytics.
Kincell Bio
Kincell Bio is dedicated to helping cell therapy innovators successfully transition from the research lab to patients with unmet medical needs. Our expertise, broad array of capabilities, and commitment to responsive, collaborative service makes Kincell the partner of choice for ambitious cell therapy programs.
Kymanox Corporation
Kymanox is a life science professional services organization that offers engineering, scientific, and compliance support to companies exclusively in the biotechnology, pharmaceutical, medical device, and combination product industries. With its diverse team, Kymanox helps clients navigate commercialization challenges that arise throughout a product's lifecycle – from early development to post-market commercialization – with optimized safety, quality, efficacy, and accessibility.
Labcorp Biopharmaceutical CMC Services
Count on Labcorp Biopharmaceutical Chemistry, Manufacturing and Control (CMC) Services' depth of analytical expertise to help you drive progress in your drug development journey. Highly skilled in characterization, formulation development, analytical development, as well as more routine quality control (QC) testing, our Subject Matter Experts will partner with you to deftly advance your programs and help avoid common pitfalls across a broad range of modalities.
Capabilities
Lonza
Lonza is a preferred global partner to the pharmaceutical, biotech and nutrition markets. We work to enable a healthier world by supporting our customers to deliver new and innovative medicines that help treat a wide range of diseases. We achieve this by combining technological insight with world-class manufacturing, scientific expertise and process excellence. Our unparalleled breadth of offerings enables our customers to commercialize their discoveries and innovations in the healthcare industry.
MilliporeSigma
We bring 30+ years of expertise, and a global organization to integrate leading manufacturing technologies with process development, scale-up, safety testing, and the regulatory experience to meet your therapy's needs. We have more experience in this area than almost anyone else in the industry. We were the first gene therapy CDMO to produce commercial product following successful regulatory inspection.
Capabilities
Minaris Advanced Therapies
Minaris Advanced Therapies is a Contract Testing, Development and Manufacturing Organization (CTDMO) that offers advanced platforms and end-to-end solutions that enable the discovery, development, testing, manufacturing, and commercialization of cell and gene therapies. Our services and solutions accelerate time to market and support customer programs around the world.
Capabilities
Novartis Contract Manufacturing
Novartis Contract Manufacturing is a fully integrated CDMO offering end-to-end manufacturing solutions for mammalian, microbial, advanced therapies (pDNA, mRNA, siRNA, autologous cell therapies, viral vectors), oligonucleotides, drug product, device assembly and packaging to meet our clients clinical and commercial supply needs.
Pace® Life Sciences
Pace® Life Sciences offers a comprehensive suite of contract services — including CMC development, clinical trial material (CTM) manufacturing, regulatory consulting, and facility support — for the pharmaceutical, biopharmaceutical, and gene therapy industries. With a nationwide network of CDMO sites, GMP analytical labs, and support centers, we are positioned to move your program efficiently from early development through commercialization.
Capabilities
ReciBioPharm
ReciBioPharm is a contract development and manufacturing organization (CDMO) specifically established to focus on serving companies seeking to develop and commercialise advanced therapy medicinal products (ATMPs). ReciBioPharm's specialised CDMO capabilities include pre-clinical to clinical and commercial development and manufacture for new biological modalities encompassing technologies based on live viruses and viral vectors, live-microbial biopharmaceutical products, nucleic acid-based mRNA and plasmid DNA production.
Capabilities
Resilience US, Inc.
Resilience is a manufacturing and technology company dedicated to broadening access to complex medicines and protecting biopharmaceutical supply chains against disruption. Founded in 2020, the company is building a sustainable network of high-tech, end-to-end manufacturing solutions with the aim to ensure the medicines of today and tomorrow can be made quickly, safely, and at scale. Resilience seeks to offer regulatory capabilities and flexible and adaptive facilities to serve partners of all sizes.
SGS
SGS offers a comprehensive analytical support package to assure the safety, identity, potency, purity and quality of raw materials, drug substances, and drug products to support the manufacture of cell and gene therapy products. With exceptional expertise across our key biopharmaceutical pillars of biosafety, characterization, QC/release and bioanalysis, SGS supports the analytical demands for cell and gene therapy development in compliance with FDA, EMA, ICH, and WHO guidelines.
Capabilities
SK pharmteco
SK pharmteco's mission is to build strong partnerships that deliver life-saving therapies and improve patient outcomes. With seven global facilities, we support the entire product lifecycle, from development to commercial manufacturing, with a collaborative "One Team" approach focused on transparency and trust. Offering CDMO services for small molecules, cell and gene therapy, and analytical testing—connect with our experts today!
Capabilities
Vector BioMed
Vector BioMed is a state-of-the-art vector CVDMO specializing in high titer, high quality, and affordable lentiviral vectors that are manufactured in the shortest possible time. Services include turn-key solutions for vector design, vector optimization, pre-clinical manufacturing, validation, and GMP manufacturing. We enable clients to move from concept to clinic to cure to commercialization.
Capabilities
Viralgen
Viralgen is a CDMO that combines decades of technology and drug development experience in multiple platforms to support best-in-class service offerings to the gene therapy market. Through our superior technology platform, we deliver industry-leading titers and cGMP-certified quality for all AAV serotypes to our client partners, optimize the cost-of-goods, and accelerate clinical development and commercialization of life-saving genetic medicines.
Capabilities